Strategic integration PharmaLex is now part of Cencora, expanding access to a broader global pharmaceutical solutions network, which creates cross-sell opportunities for end-to-end services across pharma, biotech, and medtech segments.

Lifecycle capabilities Offer continued lifecycle support from early planning through post-approval activities, highlighting PharmaLex as a partner for regulatory submissions, non-clinical requirements, and maintenance post-launch to drive ongoing project engagements.

AMR collaboration Recent partnerships and hub initiatives with BIOASTER Cynbiose ICTA and Cynbiose to fast-track antimicrobial resistance solutions present a channel to propose targeted AMR programs, diagnostics support, and regulatory strategy services.

AMR funding-ready Strategic AMR initiatives align with potential grant- and funding-backed programs; position PharmaLex as the advisory lead for biopharma clients pursuing AMR-focused R&D to commercialization efforts.

Digital and robotics stack Technology-assisted capabilities using Azure Cognitive Services, Databricks, SQL Server, ABB robotics, and other tools enable selling data-driven, automation-enabled trial optimization, regulatory analytics, and manufacturing efficiency solutions.